Scabies: Diagnostic and Therapeutic Update
Open Access
- 30 September 2020
- journal article
- review article
- Published by SAGE Publications in Journal of Cutaneous Medicine and Surgery
- Vol. 25 (1) , 95-101
Abstract
Background: Scabies is globally ubiquitous and is a significant health issue for institutions, the economically disenfranchised, resource-poor areas, and for those with weakened immune systems. Topicals are usually effective, but are cumbersome and expensive to use in large populations and for those nonadherent to topicals. Oral ivermectin became available in Canada for the off-label treatment of scabies in the fall 2018. Objectives: To review the diagnosis and management of scabies. Dose schedules and concomitant management measures are outlined for scabies simplex and for crusted scabies. Ivermectin use is outlined. Methods: Medline, colleague discussions, practice review, and experience from managing scabies in institutions. Results: Oral ivermectin is safe, easier to use, cheaper, more effective, and more economical than topicals in widespread institutional scabies, for those nonadherent to topicals, and in crusted scabies. Conclusions: Oral ivermectin is the treatment of choice in large populations, the nonadherent, and for crusted scabies. Oral ivermectin is produced by Merck Canada as Stromectol 3 mg. The treatment dose for noncrusted scabies is 200 µg/kg, taken in a single dose with food. For example, 15 mg (5 tablets) for a 70 kg person. Retreat in 10-14 days to enhance effectiveness, and perhaps to reduce scabicide resistance.Keywords
This publication has 22 references indexed in Scilit:
- Retrospective analysis of institutional scabies outbreaks from 1984 to 2013: lessons learned and moving forwardEpidemiology and Infection, 2016
- ScabiesPaediatrics & Child Health, 2015
- Low-Cost Equipment for Diagnosis and Management of Endemic Scabies Outbreaks in Underserved PopulationsClinical Infectious Diseases, 2014
- Scabies in the developing world–-its prevalence, complications, and managementClinical Microbiology and Infection, 2012
- Lindane Toxicity: A Comprehensive Review of the Medical LiteraturePediatric Dermatology, 2011
- Permethrin and Ivermectin for ScabiesNew England Journal of Medicine, 2010
- Accuracy of standard dermoscopy for diagnosing scabiesJournal of the American Academy of Dermatology, 2007
- PARENTERAL ADMINISTRATION OF IVERMECTIN IN A PATIENT WITH DISSEMINATED STRONGYLOIDIASISThe American Journal of Tropical Medicine and Hygiene, 2005
- Scabies and pediculosisThe Lancet, 2000
- Deaths associated with ivermectin treatment of scabiesThe Lancet, 1997